Joshua A Hill1, Ruth HallSedlak2, Amalia Magaret3, Meei-Li Huang2, Danielle M Zerr4, Keith R Jerome3, Michael Boeckh5. 1. Department of Medicine, University of Washington, United States; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, United States. Electronic address: jahill3@fredhutch.org. 2. Department of Laboratory Medicine, University of Washington, United States. 3. Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, United States; Department of Laboratory Medicine, University of Washington, United States. 4. Department of Medicine, University of Washington, United States; Seattle Children's Research Institute, Seattle, WA, United States. 5. Department of Medicine, University of Washington, United States; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, United States.
Abstract
BACKGROUND: Human herpesvirus 6 (HHV-6) has a unique ability to integrate into chromosomal telomeres. Vertical transmission via germ cell integration results in offspring with inherited chromosomally integrated (ci)HHV-6 in all nucleated cells, affecting ∼1% of the population. OBJECTIVES: Inherited ciHHV-6 may be a direct or indirect mediator of human disease, but efficient identification of affected individuals is a fundamental roadblock to larger studies exploring the clinical importance of this condition. STUDY DESIGN: A group testing strategy was designed to efficiently identify individuals with inherited ciHHV-6. DNA was extracted from 2496 cellular samples from hematopoietic cell transplant (HCT) donor-recipient pairs. Pools of 12 samples were screened for HHV-6 DNA with quantitative (q)PCR. Individual samples from high positive pools were tested with qPCR, and high positive individual samples were tested for inherited ciHHV-6 using droplet digital (dd)PCR to determine HHV-6 DNA copies/cellular genome. RESULTS: Thirty-one pools had high positive HHV-6 DNA detection with >10(3) HHV-6 DNA copies/μg. Each pool had one sample with >10(4) copies/μg HHV-6 DNA. Inherited ciHHV-6 was confirmed by ddPCR in every high positive sample (>10(3) HHV-6 DNA copies/μg), yielding a prevalence of 1.5% in HCT recipients and 0.96% in donors. We performed 580 qPCR tests to screen 2496 samples for inherited ciHHV-6, a 77% reduction in testing. CONCLUSIONS: Inherited ciHHV-6 can be efficiently identified by specimen pooling coupled with modern molecular techniques. This algorithm can be used to facilitate cost-effective identification of patients with inherited ciHHV-6, thereby removing a major hurdle for large-scale study of its clinical impact.
BACKGROUND:Human herpesvirus 6 (HHV-6) has a unique ability to integrate into chromosomal telomeres. Vertical transmission via germ cell integration results in offspring with inherited chromosomally integrated (ci)HHV-6 in all nucleated cells, affecting ∼1% of the population. OBJECTIVES: Inherited ciHHV-6 may be a direct or indirect mediator of human disease, but efficient identification of affected individuals is a fundamental roadblock to larger studies exploring the clinical importance of this condition. STUDY DESIGN: A group testing strategy was designed to efficiently identify individuals with inherited ciHHV-6. DNA was extracted from 2496 cellular samples from hematopoietic cell transplant (HCT) donor-recipient pairs. Pools of 12 samples were screened for HHV-6 DNA with quantitative (q)PCR. Individual samples from high positive pools were tested with qPCR, and high positive individual samples were tested for inherited ciHHV-6 using droplet digital (dd)PCR to determine HHV-6 DNA copies/cellular genome. RESULTS: Thirty-one pools had high positive HHV-6 DNA detection with >10(3) HHV-6 DNA copies/μg. Each pool had one sample with >10(4) copies/μg HHV-6 DNA. Inherited ciHHV-6 was confirmed by ddPCR in every high positive sample (>10(3) HHV-6 DNA copies/μg), yielding a prevalence of 1.5% in HCT recipients and 0.96% in donors. We performed 580 qPCR tests to screen 2496 samples for inherited ciHHV-6, a 77% reduction in testing. CONCLUSIONS: Inherited ciHHV-6 can be efficiently identified by specimen pooling coupled with modern molecular techniques. This algorithm can be used to facilitate cost-effective identification of patients with inherited ciHHV-6, thereby removing a major hurdle for large-scale study of its clinical impact.
Authors: Raymund R Razonable; Cara Fanning; Robert A Brown; Mark J Espy; Antonio Rivero; Jennie Wilson; Walter Kremers; Thomas F Smith; Carlos V Paya Journal: J Infect Dis Date: 2001-12-14 Impact factor: 5.226
Authors: Annie Gravel; Isabelle Dubuc; Guillaume Morissette; Ruth H Sedlak; Keith R Jerome; Louis Flamand Journal: Proc Natl Acad Sci U S A Date: 2015-06-15 Impact factor: 11.205
Authors: Ruth Hall Sedlak; Linda Cook; Meei-Li Huang; Amalia Magaret; Danielle M Zerr; Michael Boeckh; Keith R Jerome Journal: Clin Chem Date: 2014-03-04 Impact factor: 8.327
Authors: Philip E Pellett; Dharam V Ablashi; Peter F Ambros; Henri Agut; Mary T Caserta; Vincent Descamps; Louis Flamand; Agnès Gautheret-Dejean; Caroline B Hall; Rammurti T Kamble; Uwe Kuehl; Dirk Lassner; Irmeli Lautenschlager; Kristin S Loomis; Mario Luppi; Paolo Lusso; Peter G Medveczky; Jose G Montoya; Yasuko Mori; Masao Ogata; Joshua C Pritchett; Sylvie Rogez; Edward Seto; Katherine N Ward; Tetsushi Yoshikawa; Raymund R Razonable Journal: Rev Med Virol Date: 2011-11-04 Impact factor: 6.989
Authors: Yan Huang; Alberto Hidalgo-Bravo; Enjie Zhang; Victoria E Cotton; Aaron Mendez-Bermudez; Gunjan Wig; Zahara Medina-Calzada; Rita Neumann; Alec J Jeffreys; Bruce Winney; James F Wilson; Duncan A Clark; Martin J Dyer; Nicola J Royle Journal: Nucleic Acids Res Date: 2013-09-19 Impact factor: 16.971
Authors: Joshua C Pritchett; Jaime S Green; Angela M Thomm; Konstance K Knox; Michael R Verneris; Troy C Lund Journal: J Infect Dis Date: 2016-10-04 Impact factor: 5.226
Authors: Derek J Hanson; Olga Tsvetkova; Guilhem F Rerolle; Alexander L Greninger; Allesandro Sette; Lichen Jing; Victoria L Campbell; David M Koelle Journal: J Virol Date: 2019-06-28 Impact factor: 5.103
Authors: Madeleine R Heldman; Darren J Wight; Pakorn Aiewsakun; Amr Aswad; Min Fang; Pavitra Roychoudhury; Terry Stevens-Ayers; Keith R Jerome; Danielle M Zerr; Alexander L Greninger; Benedikt B Kaufer; Michael Boeckh; Joshua A Hill Journal: J Virol Date: 2022-08-25 Impact factor: 6.549
Authors: Daniel P Weschke; Wendy M Leisenring; Richard L Lawler; Terry Stevens-Ayers; Meei-Li Huang; Keith R Jerome; Danielle M Zerr; John A Hansen; Michael Boeckh; Joshua A Hill Journal: Biol Blood Marrow Transplant Date: 2019-10-31 Impact factor: 5.742
Authors: Joshua A Hill; Amalia S Magaret; Ruth Hall-Sedlak; Anna Mikhaylova; Meei-Li Huang; Brenda M Sandmaier; John A Hansen; Keith R Jerome; Danielle M Zerr; Michael Boeckh Journal: Blood Date: 2017-06-08 Impact factor: 22.113
Authors: Lisa K Vande Vusse; Mark M Wurfel; David M Madtes; H Gary Schoch; Susanna Harju-Baker; Joshua A Hill; Keith R Jerome; Michael Boeckh; Timothy R Watkins Journal: Bone Marrow Transplant Date: 2018-04-18 Impact factor: 5.483
Authors: Amr Aswad; Giulia Aimola; Darren Wight; Pavitra Roychoudhury; Cosima Zimmermann; Joshua Hill; Dirk Lassner; Hong Xie; Meei-Li Huang; Nicholas F Parrish; Heinz-Peter Schultheiss; Cristina Venturini; Susanne Lager; Gordon C S Smith; D Stephen Charnock-Jones; Judith Breuer; Alexander L Greninger; Benedikt B Kaufer Journal: Mol Biol Evol Date: 2021-01-04 Impact factor: 16.240
Authors: Alexander L Greninger; Giselle M Knudsen; Pavitra Roychoudhury; Derek J Hanson; Ruth Hall Sedlak; Hong Xie; Jon Guan; Thuy Nguyen; Vikas Peddu; Michael Boeckh; Meei-Li Huang; Linda Cook; Daniel P Depledge; Danielle M Zerr; David M Koelle; Soren Gantt; Tetsushi Yoshikawa; Mary Caserta; Joshua A Hill; Keith R Jerome Journal: BMC Genomics Date: 2018-03-20 Impact factor: 3.969